Vismodegib for treatment of periocular basal cell carcinoma - 6-year experience from a tertiary cancer center,

• मुख्य लेखकों: Catarina Xavier (लेखक), Edgar Lopes (लेखक), Catarina Bexiga (लेखक), Cecília Moura (लेखक), Emanuel Gouveia (लेखक), Ana Filipa Duarte (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Sociedade Brasileira de Dermatologia, 2022-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background: The treatment of advanced periocular basal cell carcinomas becomes a challenge as surgery may involve highly mutilating procedures. Vismodegib is the first selective hedgehog inhibitor approved for the treatment of locally advanced tumors or metastatic disease. Objective: Analyz...